Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factorFunctional capacityAssessed: 6MWT · DCM (non‐ischaemic)1 finding from 1 reviewStem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 155 participantsLow